1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
40.52%
Revenue growth above 1.5x ENPH's 2.16%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-124.82%
Negative gross profit growth while ENPH is at 2.24%. Joel Greenblatt would examine cost competitiveness or demand decline.
-481.19%
Negative EBIT growth while ENPH is at 43.08%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-2818.90%
Negative operating income growth while ENPH is at 43.08%. Joel Greenblatt would press for urgent turnaround measures.
-578.55%
Negative net income growth while ENPH stands at 29.69%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-586.21%
Negative EPS growth while ENPH is at 47.50%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-586.21%
Negative diluted EPS growth while ENPH is at 47.50%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.17%
Share reduction more than 1.5x ENPH's 30.89%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.17%
Diluted share reduction more than 1.5x ENPH's 30.89%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
478.71%
OCF growth above 1.5x ENPH's 78.81%. David Dodd would confirm a clear edge in underlying cash generation.
293.13%
FCF growth above 1.5x ENPH's 69.49%. David Dodd would verify if the firm’s strategic investments yield superior returns.
554.41%
Positive 10Y revenue/share CAGR while ENPH is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
28.41%
5Y revenue/share CAGR above 1.5x ENPH's 0.69%. David Dodd would look for consistent product or market expansions fueling outperformance.
40.91%
Positive 3Y CAGR while ENPH is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
643.25%
10Y OCF/share CAGR above 1.5x ENPH's 98.56%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
156.27%
Positive OCF/share growth while ENPH is negative. John Neff might see a comparative advantage in operational cash viability.
1197.14%
Positive 3Y OCF/share CAGR while ENPH is negative. John Neff might see a big short-term edge in operational efficiency.
-1257.38%
Negative 10Y net income/share CAGR while ENPH is at 96.57%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-133.75%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-1180.57%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-1.90%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-44.19%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-20.78%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.07%
Firm’s AR is declining while ENPH shows 2.58%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-10.16%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-10.39%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-16.78%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-28.73%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-15.25%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-16.93%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.